Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Turcot syndrome × Induction Chemotherapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nasopharyngeal Carcinoma 11 Nasopharyngeal Neoplasms 3 Leukemia, Myeloid, Acute 3 Rectal Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Turcot syndrome 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Patient Outcome Assessment 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma 1 Locally Advanced Malignant Neoplasm 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hypopharyngeal Neoplasms 1 Gastrointestinal Neoplasms 1 Esophagitis 1

Interventions

pembrolizumab 4 Nivolumab 3 sintilimab 2 Neoadjuvant Therapy 2 toripalimab 1 tislelizumab 1 spartalizumab 1 relatlimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 denileukin diftitox 1 danvatirsen 1 avelumab 1 atezolizumab 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 IMM-101 1 E7777 fusion protein 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07259473 2026-01-07

Pre-CATALIS

Shanghai Zhongshan Hospital

Phase 2 Not yet recruiting

Turcot syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡